多西紫彬醇联合卡铂每周方案治疗非小细胞肺癌37例护理体会
出处
《齐鲁护理杂志》
2007年第7期24-,共1页
Journal of Qilu Nursing
参考文献2
-
1朱利明,李秋云,余新民,马胜林.多西紫杉醇联合卡铂治疗非小细胞肺癌的临床研究[J].中华肿瘤杂志,2006,28(12):946-948. 被引量：11
-
2[3]Hotta K,ueoka H,et al.Meta-analysis of randomized clinical trials lung cancer[J].Cancer Chemother Pharmacol,2001,48:446-450.
二级参考文献10
-
1Fossella F,Pereira JR,von Pawel J,et al.Randomized,multinational,phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced nonsmall-cell lung cancer:the TAX 326 study group.J Clin Oncol,2003,21:3016-3024.
-
2Ramalingam S,Dobbs TW,Einzig AI,et al.Carboplatin and docetaxel in advanced non-small-cell lung cancer:results of a multicenter phase Ⅱ study.Cancer Chemother Pharmacol,2004,53:439-444.
-
3Millward MJ,Boyer MJ,Lehnert M,et al.Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer:a phase Ⅱ study in Caucasian and Asian patients.Ann Oncol,2003,14:449-454.
-
4Giannakakis T,Kakolyris S,Theodoropoulos E,et al.A multicenter phase Ⅱ study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.Anticancer Res,2002,22:3743-3748.
-
5Oka M,Fukuda M,Nagashima S,et al.Phase Ⅰ study of secondline chemotherapy with docetaxel and carboplatin in advanced nonsmall-cell lung cancer.Cancer Chemother Pharmacol,2001,48:446-450.
-
6Hotta K,Matsuo K,Ueoka H,et al.Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.J Clin Oncol,2004,22:3852-3859.
-
7Davies AM,Lara PN Jr,Mack PC,et al.Docetaxel in non-small cell lung cancer:a review.Expert Opin Pharmacother,2003,4:553-565.
-
8Kasahara K,Myo S,Iwasa K,et al.A phase I study of carboplatin and docetaxel for advanced non-small cell lung cancer using the continual reassessment method.Jpn J Clin Oncol,2002,32:512-516.
-
9Yamamoto N,Tamura T,Murakami H,et al.Randomized pharmacokinetic and pharmacodynamic study of docetaxel:dosing based on body-surface area compared with individualized dosing based on cytochrome P450 activity estimated using a urinary metabolite of exogenous cortisol.J Clin Oncol,2005,23:1061-1069.
-
10储大同,罗扬,李峻岭,郝学志,张湘茹,李雅玲.卡铂按AUC给药对小细胞肺癌疗效和毒性的影响[J].中国肿瘤临床,2001,28(1):28-30. 被引量：13
共引文献10
-
1段孝文.紫杉醇联合顺铂氟尿嘧啶治疗晚期复发鼻咽癌的护理及临床意义[J].航空航天医药,2009,20(8):117-119. 被引量：3
-
2段孝文.紫杉醇联合顺铂氟尿嘧啶治疗晚期复发鼻咽癌的护理[J].实用医技杂志,2010,17(6):595-596.
-
3夏红雪,张志峰,刘卫平,王唤雨.多西他赛的合成工艺研究[J].河北化工,2007,30(5):38-38. 被引量：3
-
4黄慧强,蔡清清,林旭滨,汪安兰,卜庆,胡晓桦,潘战和,李宇红,双跃容,管忠震.多西紫杉醇联合氟尿嘧啶和顺铂治疗晚期复发鼻咽癌[J].中华肿瘤杂志,2008,30(4):314-316. 被引量：23
-
5王子平,孙燕,张湘茹,张茂宏,王秀问,于学军,南克俊,李恩孝,刘基巍,高亚杰,关小倩,宋恕平,盛立军,王东林,王志新.多西他赛联合多柔比星治疗一线化疗失败的非小细胞肺癌Ⅱ期临床研究[J].中华肿瘤杂志,2008,30(6):465-468. 被引量：3
-
6张五军.多西紫杉醇与吉西他滨联合PF方案治疗非小细胞肺癌的疗效比较[J].医学临床研究,2009,26(3):531-532. 被引量：1
-
7金俊.多西紫杉醇联合顺铂治疗晚期非小细胞肺癌临床疗效观察[J].中国当代医药,2009,16(21):182-182. 被引量：3
-
8田黎,孙红.不同药物治疗肺癌合并低钠血症的临床分析[J].医药论坛杂志,2011,32(19):159-160. 被引量：1
-
9陆向东,茅卫东.多西他赛联合卡铂每周和三周方案治疗晚期非小细胞肺癌的临床观察[J].现代肿瘤医学,2012,20(1):100-103. 被引量：3
-
10赵吉光.多西紫杉醇联合顺铂治疗晚期非小细胞肺癌疗效观察[J].中国肿瘤临床与康复,2013,20(8):909-911. 被引量：4
-
1郭向阳,张亚芬,李炘正.注射用紫杉醇每周方案在乳腺癌术后化疗中的不良反应[J].中国药物与临床,2013,13(12):1638-1639. 被引量：4
-
2姜丽平.鼻咽癌放疗同步顺铂治疗临床研究[J].按摩与康复医学,2012(3):82-83.
-
3王绍华,艾正友,付林,朱健伟,田彬.术前不同化疗方案联合腹腔镜胃大部分切除术治疗胃恶性肿瘤的疗效[J].局解手术学杂志,2017,26(4):274-277. 被引量：1
-
4徐庆堂,田稔秋,李波,吴爱勤,贺晓东.应用血透装置行腹水浓缩回输体会[J].沈阳部队医药,1996,9(2):180-180.
-
5霍伟,李志民,朱晓敏,李玉民.周剂量多西紫杉醇联合顺铂二线治疗进展期胃癌的临床研究[J].中国临床实用医学,2010,4(12):88-90.
